Brainstorm Cell Therapeutics Inc. (BCLI): Operating Cash Flow
-$6.97M
Year ended 2025-12-31
-$4.06M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$6.97M | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | -$9.09M | n/m | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | -$20.46M | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | -$19.32M | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$26.27M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$35.19M | n/m | 2022-03-28, From 2020-01-01 |
| 2019-12-31 | -$11.25M | n/m | 2021-02-04, From 2019-01-01 |
| 2018-12-31 | -$12.39M | n/m | 2020-02-18, From 2018-01-01 |
| 2017-12-31 | -$2.36M | n/m | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | -$5.86M | n/m | 2018-03-08, From 2016-01-01 |
| 2015-12-31 | -$7.41M | n/m | 2017-03-29, From 2015-01-01 |
| 2014-12-31 | -$4.49M | n/m | 2015-03-26, From 2014-01-01 |
| 2013-12-31 | -$4.05M | n/m | 2015-03-26, From 2013-01-01 |
| 2012-12-31 | -$2.94M | n/m | 2014-03-27, From 2012-01-01 |
| 2011-12-31 | -$2.22M | n/m | 2013-03-14, From 2011-01-01 |
| 2010-12-31 | -$2.07M | n/a | 2012-03-15, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Brainstorm Cell Therapeutics Inc. (BCLI) | 2025-12-31 | -$6.97M | n/m |
| Abpro Holdings, Inc. (ABPO) | 2025-12-31 | -$6.01M | n/m |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | -$718.0K | n/m |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | -$4.31M | n/m |
| Adaptin Bio, Inc. (APTN) | 2025-12-31 | -$4.78M | n/m |
| Liminatus Pharma, Inc. (LIMN) | 2025-12-31 | -$9.96M | n/m |
| Estrella Immunopharma, Inc. (ESLA) | 2025-12-31 | -$1.79M | n/a |
| BioCardia, Inc. (BCDA) | 2025-12-31 | -$7.44M | n/m |
| Cero Therapeutics Holdings, Inc. (CERO) | 2025-12-31 | -$16.10M | n/a |
Compare BCLI, ABPO, ZEOX, ZIVO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗